Introduction

Stroke volume is the volume of blood ejected by a ventricle during each cardiac contraction. The difference between end-diastolic volume and end-systolic volume defines stroke volume. Stroke volume is 1 of the 2 determinants of cardiac output, defined as the volume of blood ejected by a ventricle per minute and equal to the product of stroke volume and heart rate.[1] In healthy adults, normal resting stroke volume ranges between 60 and 100 mL, with variation according to body size, sex, and conditioning status. Stroke volume applies to both the right and left ventricles, although left ventricular stroke volume is most commonly referenced in clinical practice.

Stroke volume is regulated by preload, afterload, and ventricular contractility, and it varies in response to physiologic demands, such as exercise, posture, and stress. Modulation of cardiac output depends on stroke volume, supporting maintenance of cardiovascular homeostasis and adequate systemic perfusion, tissue oxygen delivery, and blood pressure regulation.[2] Dysregulation of stroke volume disrupts these processes and contributes to heart failure, hypovolemia, valvular disease, and shock, underscoring the role of stroke volume in normal cardiovascular physiology and clinical disease states.

Issues of Concern

Stroke volume is a critical determinant of cardiac output and systemic perfusion. Disturbances in preload, afterload, myocardial contractility, ventricular compliance, valvular function, or neurohormonal regulation can reduce effective stroke volume and contribute to hypotension, shock, heart failure, and impaired tissue oxygen delivery. Understanding these mechanisms is essential for evaluating cardiovascular dysfunction and guiding appropriate management.

Cellular Level

Cardiomyocytes are the primary cardiac contractile cells responsible for generating the force required for ventricular ejection. Cardiomyocytes are branching, striated muscle cells that generate force through coordinated sarcomere shortening, contributing to ventricular pressure development and systolic ejection. Structural organization, metabolic capacity, and calcium-handling properties enable myocardial adjustment of force generation in response to changes in preload, afterload, and physiologic demand.[3]

Cardiomyocytes rely predominantly on aerobic metabolism and contain abundant mitochondria and myoglobin to support sustained adenosine triphosphate (ATP) production. Adequate ATP availability is required for actin-myosin cross-bridge cycling and efficient contraction. Action potentials are initiated in pacemaker cells of the sinoatrial node and propagate across the myocardium through gap junctions, resulting in sarcolemmal depolarization.[4] This depolarization spreads via transverse tubules, activating voltage-gated L-type calcium channels. Activation results in an influx of extracellular calcium, triggering calcium release from ryanodine receptors in the sarcoplasmic reticulum. This mechanism, termed "calcium-induced calcium release," is central to myocardial contraction. Calcium binding to troponin C produces conformational changes that facilitate actin-myosin cross-bridge formation and sarcomere shortening.[5]

The magnitude and duration of intracellular calcium availability directly regulate contractile force, influencing systolic ejection and stroke volume. This structural organization ensures efficient generation of contractile force to optimize ventricular ejection.

Cardiomyocytes may undergo hypertrophic remodeling in response to sustained workload.[6] Hypertrophic remodeling occurs in 2 forms: eccentric and concentric. Eccentric hypertrophy involves addition of sarcomeres in series, resulting in elongated cardiomyocytes and enlargement of the ventricular chamber. Eccentric hypertrophy is associated with increased preload and volume overload.[7] This structural adaptation allows greater end-diastolic filling and contributes to increased stroke volume. Concentric hypertrophy involves addition of sarcomeres in parallel, resulting in increased wall thickness and reduced ventricular compliance. Concentric hypertrophy is driven by pressure overload and, over time, may impair ventricular filling, reducing end-diastolic volume and stroke volume.

Mechanism

Stroke volume is regulated primarily by preload, afterload, and contractility. Heart rate indirectly affects stroke volume by altering diastolic filling time.

Preload

"Preload" refers to the stretch of ventricular cardiomyocytes at the end of diastole. End-diastolic volume is commonly used as an estimate of preload, as end-diastolic volume represents ventricular blood volume prior to contraction.

Greater blood volume enters the ventricle during diastole as venous return increases, increasing end-diastolic volume and stretching ventricular muscle fibers, thereby increasing preload. Increased stretch increases sarcomere length and improves overlap between actin and myosin filaments. Optimized filament overlap increases the potential for cross-bridge formation and increases myofilament sensitivity to calcium. The resultant increases in contractile force allow ejection of a larger stroke volume. Excessively shortened or excessively lengthened sarcomeres reduce filament overlap, decreasing force generation and limiting stroke volume.[8]

The Frank–Starling mechanism describes the intrinsic relationship between ventricular filling and contractile force. Increased venous return and end-diastolic volume augment sarcomere stretch, resulting in increased force generation and stroke volume. This mechanism allows cardiac output to match venous return without requiring external neural or hormonal input.

Since veins are highly compliant and contain most of the body’s blood volume, changes in venous tone strongly influence venous return and preload. Venoconstriction increases venous tone, reduces venous capacitance, and raises systemic venous pressure, particularly mean systemic filling pressure, the upstream pressure that drives venous return. Increased upstream pressure increases the pressure gradient for venous return, promoting forward flow to the right atrium. Increased venous return promotes right ventricular filling, thereby augmenting right ventricular stroke volume through the Frank–Starling mechanism. Increased right ventricular output then enhances pulmonary venous return to the left heart, supporting left ventricular filling and stroke volume. Venodilation produces the opposite effect.

Central venous pressure (CVP) is the pressure in the thoracic vena cava near the right atrium and serves as a clinical estimate of right atrial pressure and right ventricular preload. In a normal heart, increased venous return may transiently increase right atrial filling and CVP, but the right ventricle responds by ejecting a greater volume of blood, allowing stroke volume to increase without a sustained rise in CVP.

Afterload

"Afterload" refers to the load that the ventricles must overcome to eject blood during systole. According to the law of Laplace, ventricular wall stress is proportional to intraventricular pressure and chamber radius and inversely proportional to wall thickness.

Clinically, left ventricular afterload is often estimated by systolic arterial pressure, since the left ventricle must generate sufficient pressure to open the aortic valve and eject blood into the arterial system. Left ventricular afterload is a dynamic variable influenced by systemic vascular resistance, arterial compliance, blood volume, autonomic vascular tone, and ventricular geometry.

Systemic vascular resistance increases mean arterial pressure and, in turn, increases left ventricular afterload. Arterial compliance determines the magnitude of pressure rise during ejection. Reduced compliance in stiff arteries increases arterial pressure and left ventricular afterload. Increased blood volume enhances venous return and cardiac output, which increases arterial pressure and left ventricular afterload. Autonomic vascular tone modulates arteriolar resistance and venous capacitance, thereby affecting arterial pressure, venous return, and afterload. Ventricular geometry directly affects wall stress. A dilated ventricle exhibits higher wall stress at a given pressure.

Increased afterload requires the ventricle to generate greater pressure to open the aortic valve and eject blood. Increased opposing pressure limits myocardial fiber shortening, resulting in greater end-systolic volume and reduced stroke volume. Reduced arterial pressure and decreased wall stress lower afterload, facilitating ejection and increasing stroke volume.[9]

Myocardial Contractility

"Contractility" refers to the intrinsic ability of the myocardium to generate force at a given preload and afterload. Contractility is primarily regulated by autonomic input, intracellular calcium availability, and sensitivity of contractile proteins to calcium.

β1-adrenergic receptors are G protein-coupled receptors located on cardiomyocytes and are activated by sympathetic stimulation, primarily through norepinephrine released from sympathetic postganglionic neurons, as well as circulating epinephrine from the adrenal medulla. Activation of β1-adrenergic receptors increases cyclic adenosine monophosphate, which activates protein kinase A. Protein kinase A enhances calcium influx through L-type calcium channels and increases calcium release from the sarcoplasmic reticulum, thereby increasing cross-bridge cycling, contractile force, and stroke volume.

Parasympathetic influence on myocardial contractility in the ventricles is minimal. Parasympathetic regulation of stroke volume occurs mainly indirectly through effects on heart rate, atrioventricular conduction, and ventricular filling, rather than through a strong direct negative inotropic effect on ventricular myocardium.

Heart Rate

Heart rate influences stroke volume indirectly by altering the time available for diastolic filling. Increased heart rate shortens diastole, reducing ventricular filling, decreasing end-diastolic volume, and lowering stroke volume, particularly at very high heart rates. Reduced heart rate increases diastolic filling time, increasing end-diastolic volume and enhancing stroke volume through the Frank–Starling mechanism. The effect of heart rate on stroke volume depends on the magnitude of heart rate change and the associated autonomic state.

Related Testing

Evaluation of stroke volume relies on both invasive and noninvasive diagnostic techniques. Accurate assessment of stroke volume is essential for the diagnosis of cardiovascular pathology, including heart failure and valvular disease.

Noninvasive Imaging

Echocardiography is the most widely used noninvasive technique for measurement of stroke volume.[10] Two-dimensional imaging enables measurement of left ventricular outflow tract diameter in the parasternal long-axis view, which, combined with Doppler velocity measurements, allows calculation of stroke volume. Doppler ultrasound further quantifies blood flow velocity, providing a functional assessment of stroke volume. Cardiac magnetic resonance imaging is considered the gold standard for noninvasive stroke volume assessment, providing precise volumetric measurements and superior reproducibility compared with echocardiography.[11]

Invasive Imaging

Invasive techniques are indicated in cases where noninvasive imaging is inconclusive, or more detailed hemodynamic information is required. Cardiac catheterization allows direct measurement of intracardiac pressures and volumetric flow, while thermodilution techniques provide an additional method for calculation of stroke volume. These invasive techniques are useful in complex cardiac disease, advanced heart failure, and preoperative assessment for cardiac surgery.

Pathophysiology

Core mechanistic disturbances to stroke volume include changes in preload, myocardial contractility, afterload, and ventricular compliance, as well as structural abnormalities and maladaptive neurohormonal compensatory mechanisms. These alterations may occur individually or in combination and contribute to impaired stroke volume regulation.

Alterations in preload affect stroke volume through changes in venous return and ventricular filling. Hypovolemia, resulting from hemorrhage or dehydration, reduces circulating blood volume and decreases venous return and end-diastolic volume. Reduced myocardial fiber stretch decreases contractile force through the Frank–Starling mechanism, leading to reduced stroke volume. Venous pooling, driven by venodilation, increases venous capacitance and reduces effective venous return. Despite normal total blood volume, reduced preload limits ventricular filling and lowers stroke volume. Excess preload initially increases stroke volume through enhanced myocardial stretch and improved contractile force. Sustained or excessive preload increases ventricular wall stress and myocardial oxygen demand, eventually impairing contractile efficiency and promoting maladaptive remodeling, with subsequent reduction in effective stroke volume.

Impaired myocardial contractility arises from conditions that reduce effective force generation by the myocardium. Myocardial ischemia decreases ATP production and impairs actin–myosin cross-bridge cycling, while myocardial infarction produces myocyte necrosis and loss of contractile tissue. Both processes increase end-systolic volume and reduce stroke volume.[12] Cardiomyopathies further contribute to contractile dysfunction. Dilated cardiomyopathy weakens systolic contraction, increasing end-systolic volume and reducing stroke volume. Hypertrophic cardiomyopathy primarily impairs diastolic filling due to reduced compliance, limiting preload and decreasing stroke volume despite preserved or increased contractility.[13] Myocarditis introduces inflammatory injury to cardiomyocytes, disrupting contractile function and impairing electrical conduction, with resultant increases in end-systolic volume and reductions in stroke volume.

Abnormal afterload contributes to stroke volume reduction through increased resistance to ventricular ejection. Systemic hypertension elevates arterial pressure and increases left ventricular afterload. The left ventricle must generate higher pressure to eject blood, increasing end-systolic volume and decreasing stroke volume. Chronic pressure overload promotes ventricular hypertrophy and increases myocardial oxygen demand.[14] Pulmonary hypertension increases pulmonary vascular resistance and right ventricular afterload, reducing right ventricular stroke volume. Reduced pulmonary blood flow subsequently decreases left ventricular preload, indirectly reducing left ventricular stroke volume.

Ventricular compliance and filling abnormalities reduce stroke volume by limiting diastolic filling and end-diastolic volume. Diastolic dysfunction involves reduced ventricular compliance and impaired relaxation, limiting ventricular filling. Systolic contractility may be preserved. However, reduced end-diastolic volume decreases stroke volume, as observed in heart failure with preserved ejection fraction. Restrictive cardiomyopathy produces marked myocardial stiffening that severely limits ventricular expansion during diastole, reducing preload and stroke volume despite normal or near-normal systolic function. Pericardial tamponade results from accumulation of pericardial fluid, which increases intrapericardial pressure and compresses the ventricles, restricting diastolic filling and directly lowering end-diastolic volume and stroke volume. Constrictive pericarditis involves fibrotic thickening of the pericardium that mechanically restricts ventricular expansion, limiting diastolic filling and reducing preload and stroke volume.

Valvular and structural abnormalities reduce stroke volume through regurgitant flow, impaired filling, or ineffective forward ejection. Mitral regurgitation results in systolic backflow of left ventricular output into the left atrium. Total stroke volume may be preserved, though forward stroke volume into the systemic circulation is reduced. Aortic regurgitation produces diastolic backflow from the aorta into the left ventricle, increasing ventricular volume load. Progressive dilation and increased wall stress impair contractile efficiency and reduce effective forward stroke volume. Mitral stenosis obstructs left atrial emptying, thereby limiting ventricular filling, reducing preload, and decreasing stroke volume.

Ventricular septal defects create left-to-right shunting, allowing a portion of left ventricular output to recirculate through the pulmonary circulation, thereby reducing effective systemic stroke volume despite normal total ejection.[15] Remodeling after myocardial infarction involves loss of contractile myocardium with subsequent ventricular dilation and geometric distortion. Increased wall stress and progressive remodeling impair systolic efficiency and reduce stroke volume.[16]

Neurohormonal and compensatory mechanisms influence stroke volume through acute augmentation of cardiac performance and chronic structural remodeling. Sympathetic activation and β1 stimulation increase heart rate and contractility, thus improving stroke volume temporarily. Persistent sympathetic stimulation increases myocardial oxygen demand and promotes maladaptive remodeling, ultimately impairing contractile function and reducing stroke volume. Renin–angiotensin–aldosterone system activation increases afterload and promotes sodium and water retention, increasing preload. Although initially supportive of cardiac output, chronic activation exacerbates pressure and volume overload, worsening ventricular dysfunction and lowering stroke volume.

Ventricular hypertrophy and dilation are structural compensatory responses to altered loading conditions. Pressure overload induces concentric hypertrophy, increasing wall thickness to normalize wall stress but reducing compliance. Volume overload promotes ventricular dilation, increasing wall stress and reducing systolic efficiency. Both adaptive responses may ultimately reduce stroke volume.[17]

Clinical Significance

Stroke volume is a key hemodynamic parameter that links cardiac physiology to systemic perfusion and end-organ function. Alterations in stroke volume provide an early indicator of cardiovascular decompensation and guide diagnostic evaluation and therapeutic intervention across a broad range of cardiac and systemic diseases.

Alterations in Preload

Preload abnormalities affect ventricular filling and directly influence stroke volume and cardiac output. Recognition of preload-related disorders is essential because timely intervention can improve perfusion, prevent cardiovascular decompensation, and reduce morbidity and mortality.

Hypovolemia presents with hypotension, tachycardia, decreased urine output, and clinical signs of poor perfusion. Diagnosis is guided by clinical assessment and hemodynamic monitoring. Management focuses on rapid volume resuscitation using intravenous fluids or blood products. Early correction improves organ perfusion and reduces mortality, whereas delayed treatment increases the risk of shock and multiorgan failure.

Venous pooling occurs in distributive shock states such as sepsis and anaphylaxis, where reduced vascular tone decreases effective venous return. Clinical presentation includes hypotension, tachycardia, and signs of poor perfusion, with warm extremities and bounding pulses sometimes observed early, particularly in sepsis. Diagnosis relies on clinical findings, laboratory evaluation, and identification of the underlying source. Treatment includes fluid resuscitation, vasopressor support when required, and targeted therapy such as antibiotics for sepsis or epinephrine for anaphylaxis. Outcomes depend on early recognition and rapid hemodynamic stabilization.

Excess preload presents with pulmonary edema, peripheral edema, and elevated jugular venous pressure, reflecting systemic fluid overload. Diagnosis involves physical examination, imaging studies, and measurement of B-type natriuretic peptide levels. Management includes diuretic administration, fluid restriction, and treatment of underlying renal or cardiac dysfunction. Persistent volume overload is associated with worse heart failure outcomes and increased hospitalization rates.

Impaired Myocardial Contractility

Myocardial contractility impairment reflects disruption of intrinsic ventricular force generation and is a major contributor to cardiac dysfunction. The clinical presentation and prognosis depend on the underlying cause and the extent of myocardial involvement.

Ischemic injury and myocardial infarction present with chest pain, electrocardiogram changes, and elevated cardiac enzymes. Rapid reperfusion therapy, including percutaneous coronary intervention or thrombolysis, is essential to limit myocardial damage. Long-term management focuses on prevention of ventricular remodeling and recurrent ischemic events. Delayed treatment is associated with increased morbidity and mortality.

Cardiomyopathies manifest with heterogeneous clinical features, depending on subtype and severity. Dilated cardiomyopathy commonly presents with progressive heart failure symptoms and reduced ejection fraction on echocardiography. Management typically includes administration of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, β-receptor blockers, or mineralocorticoid receptor antagonists. Hypertrophic cardiomyopathy may present with dyspnea, syncope, or risk of sudden cardiac death. Management may include the use of β-receptor blockers or calcium channel blockers, as well as septal reduction therapy. Prognosis varies according to disease severity and arrhythmic risk.

Myocarditis presents with chest pain, heart failure symptoms, or arrhythmias. Diagnosis may involve cardiac magnetic resonance imaging or endomyocardial biopsy in selected cases. Management is largely supportive, with emphasis on heart failure therapy and arrhythmia control. Clinical outcomes range from complete recovery to progression into chronic cardiomyopathy.

Abnormal Afterload 

Disorders associated with abnormal afterload increase the resistance encountered during ventricular ejection and contribute to progressive cardiovascular disease. Early recognition and appropriate management are important for preventing adverse cardiac and systemic complications.

Systemic hypertension is often asymptomatic until cardiovascular or end-organ complications develop. Diagnosis relies on blood pressure measurement and evaluation for evidence of end-organ injury. Management includes lifestyle modification and antihypertensive therapy. Effective blood pressure control reduces the risk of heart failure, stroke, and chronic kidney disease.

Pulmonary hypertension commonly presents with exertional dyspnea and clinical features of right heart strain. Diagnosis requires echocardiography, followed by confirmatory right heart catheterization. Management is guided by the underlying etiology and may include pulmonary vasodilator use, oxygen therapy in the presence of hypoxemia, anticoagulation in selected cases (eg, chronic thromboembolic pulmonary hypertension), and treatment of the underlying disease process. Prognosis varies considerably according to disease severity and etiology but generally worsens with delayed diagnosis and treatment.

Ventricular Compliance and Filling Abnormalities

Abnormalities of ventricular filling alter cardiac hemodynamics and can significantly impair functional capacity and cardiovascular stability. Clinical outcomes depend on the underlying etiology, severity of filling impairment, and timeliness of intervention.

Diastolic dysfunction typically presents with exertional dyspnea and preserved ejection fraction on cardiac imaging. Diagnosis is based on echocardiographic assessment of diastolic function. Management focuses on blood pressure control, diuretic therapy for congestion, and treatment of associated comorbidities. Rates of hospitalization and mortality are often comparable to those observed in heart failure with reduced ejection fraction.

Restrictive cardiomyopathy commonly presents with progressive heart failure symptoms despite preserved systolic function. Management is primarily supportive, and prognosis varies according to the underlying cause.

Pericardial tamponade presents with hypotension, jugular venous distention, and muffled heart sounds. Echocardiography confirms the diagnosis. Urgent pericardiocentesis is lifesaving and remains the treatment of choice. Delayed intervention may result in rapid cardiovascular collapse.

Constrictive pericarditis produces chronic right-sided heart failure symptoms due to impaired ventricular filling. Medical management may include diuretic administration for congestion and anti-inflammatory therapy when active inflammation is present. Definitive treatment for chronic symptomatic disease is surgical pericardiectomy. Pericardiocentesis is reserved for cases with a significant associated pericardial effusion or effusive-constrictive physiology. Early recognition and appropriate intervention improve long-term outcomes.

Valvular and Structural Abnormalities

Structural abnormalities of the heart and cardiac valves are important causes of hemodynamic impairment and heart failure. Clinical consequences depend on the severity of the underlying lesion and the extent of compensatory remodeling.

Mitral regurgitation may remain asymptomatic during the early stages of disease but can eventually present with dyspnea and atrial fibrillation. Echocardiography is used to determine disease severity. Management ranges from medical therapy to surgical or transcatheter valve repair. Early intervention before the development of ventricular dysfunction is associated with improved survival.

Aortic regurgitation may be well tolerated for prolonged periods before ventricular dilation or systolic dysfunction becomes evident. Serial imaging studies guide the timing of valve replacement, which is recommended in the presence of symptoms, left ventricular systolic dysfunction, or significant ventricular dilation, even in asymptomatic individuals. Delayed surgery increases the risk of irreversible ventricular dysfunction.

Mitral stenosis commonly presents with dyspnea and atrial fibrillation. Echocardiography confirms disease severity. Management includes rate control, anticoagulation, and balloon valvotomy or surgical intervention in advanced disease. Untreated severe mitral stenosis increases the risk of thromboembolic events and heart failure.

Ventricular septal defects vary in clinical significance according to defect size. Smaller defects may be managed conservatively with observation, whereas larger defects often require surgical or percutaneous closure. Persistent shunting increases the risk of pulmonary hypertension and heart failure.

Ventricular remodeling following myocardial infarction increases the risk of progressive heart failure and cardiac arrhythmias. Early initiation of appropriate medical therapy reduces adverse remodeling and improves survival.

Maladaptive Neurohormonal and Compensatory Mechanisms

Neurohormonal activation and structural remodeling are important determinants of cardiovascular adaptation to hemodynamic stress. Long-term activation of these pathways is associated with progressive ventricular dysfunction and increased morbidity and mortality.

Sympathetic activation and β1-adrenergic stimulation provide short-term support of systemic perfusion during acute illness. However, chronic sympathetic activation contributes to arrhythmogenesis and progressive heart failure. β-receptor blockers are a cornerstone of long-term management and are associated with improved survival.

Activation of the renin–angiotensin–aldosterone system promotes fluid retention and increased vascular resistance. Pharmacologic inhibition or modulation of this pathway by administering angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, angiotensin receptor-neprilysin inhibitors, or mineralocorticoid receptor antagonists reduces morbidity and mortality in appropriately selected patients with heart failure, particularly heart failure with reduced ejection fraction, as well as in selected patients with left ventricular dysfunction following myocardial infarction.

Ventricular hypertrophy and dilation are forms of structural remodeling associated with adverse cardiovascular outcomes. Early pharmacologic intervention and effective blood pressure control reduce disease progression and improve long-term survival.

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Sara JDS, Toya T, Ahmad A, Clark MM, Gilliam WP, Lerman LO, Lerman A. Mental Stress and Its Effects on Vascular Health. Mayo Clin Proc. 2022 May;97(5):951-990. [PMC free article: PMC9058928] [PubMed: 35512885]

2.

LaCombe P, Jose A, Basit H, Lappin SL. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 4, 2023. Physiology, Starling Relationships. [PubMed: 29083674]

3.

Woodcock EA, Matkovich SJ. Cardiomyocytes structure, function and associated pathologies. Int J Biochem Cell Biol. 2005 Sep;37(9):1746-51. [PubMed: 15950518]

4.

Bers DM. Cardiac excitation-contraction coupling. Nature. 2002 Jan 10;415(6868):198-205. [PubMed: 11805843]

5.

Kushnir A, Marks AR. The ryanodine receptor in cardiac physiology and disease. Adv Pharmacol. 2010;59:1-30. [PMC free article: PMC3023997] [PubMed: 20933197]

6.

Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000 Mar 01;35(3):569-82. [PubMed: 10716457]

7.

Mihl C, Dassen WR, Kuipers H. Cardiac remodelling: concentric versus eccentric hypertrophy in strength and endurance athletes. Neth Heart J. 2008 Apr;16(4):129-33. [PMC free article: PMC2300466] [PubMed: 18427637]

8.

Squire J. Special Issue: The Actin-Myosin Interaction in Muscle: Background and Overview. Int J Mol Sci. 2019 Nov 14;20(22) [PMC free article: PMC6887992] [PubMed: 31739584]

9.

Mason DT. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure. Am J Med. 1978 Jul;65(1):106-25. [PubMed: 99030]

10.

Sattin M, Burhani Z, Jaidka A, Millington SJ, Arntfield RT. Stroke Volume Determination by Echocardiography. Chest. 2022 Jun;161(6):1598-1605. [PubMed: 35085589]

11.

Thavendiranathan P, Liu S, Datta S, Walls M, Nitinunu A, Van Houten T, Tomson NA, Vidmar L, Georgescu B, Wang Y, Srinivasan S, De Michelis N, Raman SV, Ryan T, Vannan MA. Automated quantification of mitral inflow and aortic outflow stroke volumes by three-dimensional real-time volume color-flow Doppler transthoracic echocardiography: comparison with pulsed-wave Doppler and cardiac magnetic resonance imaging. J Am Soc Echocardiogr. 2012 Jan;25(1):56-65. [PubMed: 22105057]

12.

Singhania N, Bansal S, Mohandas S, Nimmatoori DP, Ejaz AA, Singhania G. Role of renin-angiotensin-aldosterone system inhibitors in heart failure and chronic kidney disease. Drugs Context. 2020;9 [PMC free article: PMC7673621] [PubMed: 33240389]

13.

Hayashi H, Abe Y, Morita Y, Yamaji Y, Nakane E, Haruna Y, Haruna T, Inoko M. Impact of stroke volume on prognostic outcome in patients with atrial fibrillation and concomitant heart failure with preserved ejection fraction. J Cardiol. 2019 Apr;73(4):307-312. [PubMed: 30587456]

14.

Farris SD, Moussavi-Harami F, Stempien-Otero A. Heart failure with preserved ejection fraction and skeletal muscle physiology. Heart Fail Rev. 2017 Mar;22(2):141-148. [PMC free article: PMC5487258] [PubMed: 28255866]

15.

Snir AD, Ng MK, Strange G, Playford D, Stewart S, Celermajer DS. The prognostic significance of stroke volume index in low gradient severe aortic stenosis: from the national echo database of Australia. Int J Cardiovasc Imaging. 2023 Sep;39(9):1719-1727. [PMC free article: PMC10520126] [PubMed: 37300593]

16.

Leancă SA, Crișu D, Petriș AO, Afrăsânie I, Genes A, Costache AD, Tesloianu DN, Costache II. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life (Basel). 2022 Jul 24;12(8) [PMC free article: PMC9332014] [PubMed: 35892913]

17.

Grossman W, Paulus WJ. Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling. J Clin Invest. 2013 Sep;123(9):3701-3. [PMC free article: PMC3754273] [PubMed: 23999445]

Disclosure: Bassem Khalil declares no relevant financial relationships with ineligible companies.

Disclosure: Celia Foster declares no relevant financial relationships with ineligible companies.

Disclosure: Marjorie Launico declares no relevant financial relationships with ineligible companies.